Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713477 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marwa Zafarullah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Proteomics, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder associated with the FMR1 premutation. Currently, it is not possible to determine when and if individual premutation carriers will develop FXTAS. Thus, with the aim to identify biomarkers for early diagnosis, development, and progression of FXTAS, along with associated dysregulated pathways, we performed blood proteomic profiling of premutation carriers (PM) who, as part of an ongoing longitudinal study, emerged into two distinct groups: those who developed symptoms of FXTAS (converters, CON) over time (at subsequent visits) and those who did not (non-converters, NCON). We compared these groups to age-matched healthy controls (HC). We assessed CGG repeat allele size by Southern blot and PCR analysis. The proteomic profile was obtained by liquid chromatography mass spectrometry (LC-MS/MS). We identified several significantly differentiated proteins between HC and the PM groups at Visit 1 (V1), Visit 2 (V2), and between the visits. We further reported the dysregulated protein pathways, including sphingolipid and amino acid metabolism. Our findings are in agreement with previous studies showing that pathways involved in mitochondrial bioenergetics, as observed in other neurodegenerative disorders, are significantly altered and appear to contribute to the development of FXTAS. Lastly, we compared the blood proteome of the PM who developed FXTAS over time with the CSF proteome of the FXTAS patients recently reported and found eight significantly differentially expressed proteins in common. To our knowledge, this is the first report of longitudinal proteomic profiling and the identification of unique biomarkers and dysregulated protein pathways in FXTAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
- Genome Center, Bioinformatics Core, University of California Davis, Davis, CA 95616, USA.
- Genome Center, Proteomics Core, Genome and Biomedical Sciences Facility, University of California Davis, Davis, CA 95616, USA.
- Division of Biostatistics, School of Medicine, University of California Davis, Davis, CA 95616, USA.
- MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
- Department of Pediatrics, University of California Davis Medical Center, Sacramento, CA 95817, USA.
ORCID-Profile: Marwa Zafarullah, Brett S Phinney, Randi Hagerman, Susan M Rivera, Flora Tassone
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Zafarullah, M., Li, J., Salemi, M. R., Phinney, B. S., Durbin-Johnson, B. P., Hagerman, R., Hessl, D., Rivera, S. M., & Tassone, F. (2023). Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713477
Vancouver
Zafarullah M, Li J, Salemi MR, Phinney BS, Durbin-Johnson BP, Hagerman R, et al. Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713477
BibTeX
@article{Zafarullah2023,
author = {Zafarullah, Marwa and Li, Jie and Salemi, Michelle R and Phinney, Brett S and Durbin-Johnson, Blythe P and Hagerman, Randi and Hessl, David and Rivera, Susan M and Tassone, Flora},
title = {Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713477}
}
EUVIMED